Morgan Stanley lowered its price target on United Therapeutics on July 19, 2025.
1 report, 1 independent
Updated Jul 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley lowered its price target on United Therapeutics on July 19, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
United Therapeutics
biotech company based in Silver Spring, Maryland, United States
Nothing else this week.
-
Morgan Stanley
U.S. investment bank
Related events
- Morgan Stanley lowered its target price for Clorox stock on October 25, 2026.
- Morgan Stanley increased its price target for SLM Corporation on September 2, 2026.
- Morgan Stanley raised its price target for United Airlines on June 30, 2026.
- Morgan Stanley set a $38.00 target price for Kinder Morgan on August 16, 2026.
- Morgan Stanley adjusted its price target for PNC Financial Services on July 3, 2025.
Coverage
Newest first; wire copies grouped- Insider MonkeyMorgan Stanley Trims United Therapeutics (UTHR) Price Target, Maintains Buy Rating United Therapeutics Corporation (NASDAQ:UTHR) is one of the high-margin pharma stocks to buy now. Morgan Stanley has